首页> 外国专利> RECOMBINANT PLASMID DNA PESG ENCODING FUSED PROTEIN SYNTHESIS THAT SHOWS ANTIGENIC PROPERTY OF HUMAN T-CELLULAR LEUKOSIS I-TYPE VIRUS SURFACE GLYCOPROTEID ENVELOPE (HTLV-I), METHOD OF ITS CONSTRUCTION AND STRAIN OF BACTERIUM ESCHERICHIA COLI HB 101/PESG - PRODUCER OF FUSED PROTEIN

RECOMBINANT PLASMID DNA PESG ENCODING FUSED PROTEIN SYNTHESIS THAT SHOWS ANTIGENIC PROPERTY OF HUMAN T-CELLULAR LEUKOSIS I-TYPE VIRUS SURFACE GLYCOPROTEID ENVELOPE (HTLV-I), METHOD OF ITS CONSTRUCTION AND STRAIN OF BACTERIUM ESCHERICHIA COLI HB 101/PESG - PRODUCER OF FUSED PROTEIN

机译:重组融合质粒DNA PESG编码融合蛋白的合成,显示人类T细胞白血病I型病毒表面糖蛋白包膜(HTLV-I)的抗原性,其构建方法和菌株大肠杆菌蓝球菌肠球菌HB 101 / PE

摘要

FIELD: genetic engineering, biotechnology. SUBSTANCE: recombinant plasmid DNA PESG (size is 5.6 thousand nucleotide pairs) consists of SalGI-BamHI-fragment (426 nucleotide pairs) of region sequence env HTLV-I and SalGI-fragment of plasmid pUR291 (size is 5.2 thousand nucleotide pairs) with beta-galactosidase gene, region ori and genetic marker as bla-gene (resistance to ampicillin) and has the unique restriction sites to BamHI, PstI, HindIII, StuI, ClaI, Tth111-II. Fragment (size is 426 nucleotide pairs) is excised from intermediate plasmid pBE1 using restriction enzyme SalGI and this fragment is ligated with SalGI-fragment of plasmid vector DNA pUR291 linearized by hydrolysis. After incubation competence cells of E. coli (treated with CaCl2) were transformed with obtained preparation followed by selection of transformants according their capability to grow on ampicillin-containing medium. Proposed invention ensures to obtain 400-500 mg fused protein from 1 l cell suspension of E. coli that contains specific polypeptide sequence encoded by region env of genome HTLV-I. EFFECT: construction of recombinant plasmid DNA, high level of fused protein production, construction of the strain-producer indicated above.
机译:领域:基因工程,生物技术。物质:重组质粒DNA PESG(大小为5.6千个核苷酸对)由区域序列env HTLV-1的SalGI-BamHI片段(426个核苷酸对)和质粒pUR291(大小为5.2千个核苷酸对)的SalGI片段组成-半乳糖苷酶基因,区域ori和遗传标记为bla基因(对氨苄青霉素具有抗性),并且对BamHI,PstI,HindIII,StuI,ClaI和Tth111-II具有独特的限制性位点。使用限制酶SalGI从中间质粒pBE1切下片段(大小为426个核苷酸对),并将该片段与通过水解线性化的质粒载体DNA pUR291的SalGI片段连接。孵育后,用获得的制剂转化大肠杆菌的细胞(用CaCl 2 处理),然后根据其在含有氨苄青霉素的培养基上生长的能力选择转化子。提出的发明确保从1μl大肠杆菌细胞悬液中获得400-500mg融合蛋白,其包含由基因组HTLV-1的区域env编码的特定多肽序列。效果:重组质粒DNA的构建,高水平融合蛋白的产生,上述菌株生产者的构建。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号